This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House
 
Gold Popped as U.S. Tests ISIS but Traders Need More Fundamentals

A bit of uncertainty has been removed from the market place now that the FOMC has provided deliberate, clear foresight into future QE3 policy.

Jimmy Choo Poised to Dig Its Heels Into London Stock Exchange IPO

The London Stock Exchange stands to get a bit more stylish next month with the listing of upscale shoe designer Jimmy Choo.

Growth In China's Manufacturing Industry Eases Concerns During Economy's Recovery

Growth in China's sprawling manufacturing industry unexpectedly ticked higher in September, according to a report Tuesday, easing concerns about the number two economy's recovery.

Housing and Construction to Outpace Capital Spending in Coming Years

Spending on housing and capital infrastructure are the two pillars of recovery and they both have been picking up but some say one will grow faster than the other.

Real Money Previews

Jim Cramer on the Stock Market: Choose Growth Over Value

The division between the two is growing wider and wider.

Cramer on the Biggest IPO of All Time: Alibaba Is the Real Deal

The company and its genuine CEO just may not be too good to be true.

Fed Unlikely to Rock the Boat; Why I Am Back to Shorting: Best of Kass

In highlights from his trading diary of the past week, Doug Kass writes about weak fundamentals and an expected fed funds rate rise.

Mad Money Recap

'Mad Money' Lightning Round: Transocean Is a House of Pain

Cramer says Medivation is for real, he is sticking with Exact Sciences but General Electric is hard to own.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to find the stocks he and Stephanie Link think could be HUGE winners. Click here to see them for FREE.

Stock Ideas

5 Hated Earnings Stocks You Should Love

These heavily shorted stocks could get squeezed much higher if they report positive earnings this week.

Must-See Charts: 5 Big Stocks to Sidestep the Selloff

Here's how to trade some of the biggest stocks on Wall Street.

5 Stocks Spiking on Big Volume for Your Trading Radar

Often when above-average volume moves into an equity, it precedes a large spike in volatility.

4 Health Care Stocks Triggering Breakout Trades on Unusual Volume

Keep these health care stocks rising on unusual volume on your breakout trading radar.

How to Trade the Market's Most-Active Stocks: RAD, ANR, AZO

Here's how to trade some of the most active stocks on the market right now.

MainStreet

ISIS and Your Investments -- Taking the Terror Out of Your Portfolio

Managing your investments in a market built on fear and greed.

Medical Marijuana Patients in Illinois Embrace September for Sign-Ups

The initial patient sign up process in Illinois, now in its first month, appears to have generated no controversies (yet), and over 2,000 people have signed up for the program.

Congress Is Looking for Ways to Give Your Credit Score a Boost

Proposal would shorten credit histories and erase the negative impact of paid off debt.

69% of Millennials Eye Mortgage Alternatives, Including Lease-to-Own

Millennials seek out creative strategies to become homeowners.

Financial Abuse by Profiteering Guardians Awaits Aging Boomers and Heirs

Sometimes the people you trust to care for your elderly relatives can hurt you the most financially.

Biotech

Tekmira Experimental Ebola Drug Used to Treat Stricken U.S. Doctor

Ebola patient Dr. Rick Sacra received treatment with Tekmira Pharmaceuticals' experimental ebola therapy TKM-Ebola for seven days, Nebraska Medical Center confirmed.

Gilead Sciences: A Preview of Important HIV Drug Study Results

Gilead's goal is to create new versions of its blockbuster HIV combination therapies, replacing Viread with TAF.

Northwest Bio's Almost-Toxic Debt Raise Responsible for Stock Slide

The buyers of Northwest's debt want the stock price to decline before Feb. 15, 2015, because a lower stock price also will drop the conversion price of the notes.

Beyond Wall St.

Deal News

General Electric a Decade Ahead of Siemens in Oil and Gas

General Electric, Siemens closest competitor globally has spent the better part of a decade cutting deals for energy equipment manufacturers and generally at lower prices.

Fertilizer Companies Yara, CF Industries Hold Merger Talks

Norwegian fertilizer maker Yara International is talking to Deerfield Il.-based rival CF Industries Holdings about a combination that would realize Yara's long-held ambition to expand in the U.S.

Philips Moves its Focus to Healthcare as it Splits Off Lighting

Royal Philips said it will split off and consider a sale of its $9 billion lighting unit in order to focus on its larger health and consumer lifestyles businesses.

TheStreetTV
Spin Space

Jim Cramer

Jim Cramer Says There's A Lot to Like About Carnival Cruise

Jim Cramer says he likes the Carnival Cruise quarter for various reasons.

Herb Greenberg

Why Playing the Patent-Fight Game Is Dangerous: Look at VirnetX

It's a crapshoot to play the patent game. Case in point: VirnetX

Stephanie Link

Jim Cramer and Stephanie Link Say There's More To Come From Microsoft

Microsoft announced on Tuesday it increased its dividend by 11 percent. It's the smallest percentage increase in its quarterly dividend in about 5 years.

Chris Ciaccia

Apple Shares May See Further Upside on China’s Enormous 4G User Base

Though Apple's new iPhone 6 and 6 Plus are not yet on sale in China, the country's massive adoption of 4G bodes well for Apple's future in China.

Adam Feuerstein

Tekmira Experimental Ebola Drug Used to Treat Stricken U.S. Doctor

Ebola patient Dr. Rick Sacra received treatment with Tekmira Pharmaceuticals' experimental ebola therapy TKM-Ebola for seven days, Nebraska Medical Center confirmed.

Dan Freed

Another Big IPO Is Happening This Week (No, It's Not Alibaba)

If it prices at $25 a share, the high end of the IPO range, Citizens Financial Group would raise $3.5 billion, valuing the company at $14 billion.

Ted Reed

Southwest CEO Opposes Bag Fees but He's Mistaken, Analyst Says

Southwest CEO Gary Kelly opposes bag fees but a veteran airline analyst says bag fees are right for Southwest and JetBlue.

Leon Lazaroff

Protesters Try to Take Wall Street, Settle for Broadway Sit-In

Climate change protesters, thwarted in their attempt to march on Wall Street, took over lower Broadway, singing chants and sending Tweets.

Submit an article to us!
DOW 17,075.81 -96.87 -0.56%
S&P 500 1,986.03 -8.26 -0.41%
NASDAQ 4,515.1840 -12.5050 -0.28%

Brokerage Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs